Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster.

The hamster was developed as a model to study very low density lipoprotein (VLDL) metabolism, since, as is the case in humans, the hamster liver was found to synthesize apoB-100 and not apoB-48. The effect of inhibiting fatty acid synthesis on the hepatic secretion of VLDL triglyceride (TG) and apol...

Full description

Bibliographic Details
Main Authors: CM Arbeeny, DS Meyers, KE Bergquist, RE Gregg
Format: Article
Language:English
Published: Elsevier 1992-06-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520415093
_version_ 1818716098763161600
author CM Arbeeny
DS Meyers
KE Bergquist
RE Gregg
author_facet CM Arbeeny
DS Meyers
KE Bergquist
RE Gregg
author_sort CM Arbeeny
collection DOAJ
description The hamster was developed as a model to study very low density lipoprotein (VLDL) metabolism, since, as is the case in humans, the hamster liver was found to synthesize apoB-100 and not apoB-48. The effect of inhibiting fatty acid synthesis on the hepatic secretion of VLDL triglyceride (TG) and apolipoprotein (apo) B-100 in this model was then investigated. In an in vivo study, hamsters were fed a chow diet containing 0.15% TOFA (5-tetradecyloxy-2-furancarboxylic acid), an inhibitor of acetyl-CoA carboxylase. After 6 days of treatment, plasma triglyceride and cholesterol levels were decreased by 30.2% and 11.6%, respectively. When the secretion of VLDL-TG by the liver was measured in vivo after injection of Triton WR 1339, TOFA treatment was found to decrease VLDL-TG secretion by 40%. In subsequent in vitro studies utilizing cultured primary hamster hepatocytes, incubation with 20 microM TOFA for 4 h resulted in 98% and 76% inhibition in fatty acid and triglyceride synthesis, respectively; VLDL-TG secretion was decreased by 90%. When hepatocytes were pulsed with [3H]leucine, incubation with TOFA resulted in a 50% decrease in the incorporation of radiolabel into secreted VLDL apoB-100. The results of this study indicate that inhibition of intracellular triglyceride synthesis decreases the secretion of VLDL-TG and apoB-100, and does not result in the secretion of a dense, triglyceride-depleted lipoprotein.
first_indexed 2024-12-17T19:13:52Z
format Article
id doaj.art-fb5a0a543871455282816e8fac0b7467
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-17T19:13:52Z
publishDate 1992-06-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-fb5a0a543871455282816e8fac0b74672022-12-21T21:35:48ZengElsevierJournal of Lipid Research0022-22751992-06-01336843851Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster.CM Arbeeny0DS Meyers1KE Bergquist2RE Gregg3Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543-4000.Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543-4000.Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543-4000.Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543-4000.The hamster was developed as a model to study very low density lipoprotein (VLDL) metabolism, since, as is the case in humans, the hamster liver was found to synthesize apoB-100 and not apoB-48. The effect of inhibiting fatty acid synthesis on the hepatic secretion of VLDL triglyceride (TG) and apolipoprotein (apo) B-100 in this model was then investigated. In an in vivo study, hamsters were fed a chow diet containing 0.15% TOFA (5-tetradecyloxy-2-furancarboxylic acid), an inhibitor of acetyl-CoA carboxylase. After 6 days of treatment, plasma triglyceride and cholesterol levels were decreased by 30.2% and 11.6%, respectively. When the secretion of VLDL-TG by the liver was measured in vivo after injection of Triton WR 1339, TOFA treatment was found to decrease VLDL-TG secretion by 40%. In subsequent in vitro studies utilizing cultured primary hamster hepatocytes, incubation with 20 microM TOFA for 4 h resulted in 98% and 76% inhibition in fatty acid and triglyceride synthesis, respectively; VLDL-TG secretion was decreased by 90%. When hepatocytes were pulsed with [3H]leucine, incubation with TOFA resulted in a 50% decrease in the incorporation of radiolabel into secreted VLDL apoB-100. The results of this study indicate that inhibition of intracellular triglyceride synthesis decreases the secretion of VLDL-TG and apoB-100, and does not result in the secretion of a dense, triglyceride-depleted lipoprotein.http://www.sciencedirect.com/science/article/pii/S0022227520415093
spellingShingle CM Arbeeny
DS Meyers
KE Bergquist
RE Gregg
Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster.
Journal of Lipid Research
title Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster.
title_full Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster.
title_fullStr Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster.
title_full_unstemmed Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster.
title_short Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster.
title_sort inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster
url http://www.sciencedirect.com/science/article/pii/S0022227520415093
work_keys_str_mv AT cmarbeeny inhibitionoffattyacidsynthesisdecreasesverylowdensitylipoproteinsecretioninthehamster
AT dsmeyers inhibitionoffattyacidsynthesisdecreasesverylowdensitylipoproteinsecretioninthehamster
AT kebergquist inhibitionoffattyacidsynthesisdecreasesverylowdensitylipoproteinsecretioninthehamster
AT regregg inhibitionoffattyacidsynthesisdecreasesverylowdensitylipoproteinsecretioninthehamster